The New York State Litigation Coordinating Panel on Thursday combined some 40 active cases for pre-trial litigation in New York County. Any future ranitidine-related personal injury cases filed in the state will proceed under this same action, according to the panel.
January 26, 2023 at 05:36 PM
2 minute read
Litigation against Zantac manufacturers filed in the state of New York will move forward as a consolidated action, a panel has ruled.
The New York State Litigation Coordinating Panel on Thursday combined some 40 active cases for pre-trial litigation in New York County. Any future ranitidine-related personal injury cases filed in the state will proceed under this same action, the ruling said.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
The U.S. Food and Drug Administration in 2020 announced an involuntary recall of heartburn medication ranitidine, including Zantac, citing the presence of a possible carcinogen.
